Company intelligence / Profile preview

Kiierr

Orem, Utah, United Stateskiierr.com ↗

Ownership: Private
Employees: ~35
Development stage: Commercial

Overview

Kiierr’s FDA-cleared laser caps use low-level laser therapy (LLLT) to stimulate dormant hair follicles and promote regrowth. Clinical studies cited by the company report a success rate of up to 93%, with users typically seeing results in four to eight months. The technology has demonstrated a significant increase in hair density and thickness compared to placebo groups[4][5][6].

Therapeutic areas: DermatologyEndocrinology
Modalities: DeviceNon-pharmacological therapyLow-level laser therapy (LLLT)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Kiierr.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kiierr.

Explore the full profile